Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport 2 mL dilution extension in Cervical Dystonia
NCT01753336Phase 3Completed
- Sponsor
- Ipsen
- Start
- Mar 2013
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of abobotulinumtoxinA in cervical dystonia (CD), sponsored by Ipsen. Started Mar 2013; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT01753336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753336.